Skip to main content
Clinical Trials/NL-OMON44077
NL-OMON44077
Completed
Not Applicable

The effect of olive leaf extract administration on cardiovascular health - The effect of olive leaf extract administration on cardiovascular health

niversiteit Maastricht0 sites80 target enrollmentStarted: TBDLast updated:

Overview

Phase
Not Applicable
Status
Completed
Enrollment
80

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • Healthy individuals, Age: 18\-70 years, BMI 25\-35 kg/m2, Total cholesterol levels \* 5\.0 mmol/L.

Exclusion Criteria

  • \* History of severe cardiovascular, respiratory, urogenital, gastrointestinal/hepatic, hematological/immunologic, HEENT (head, ears, eyes, nose, throat). Dermatological/connective tissue, musculoskeletal, metabolic/nutritional, endocrine, neurological diseases, allergy, major surgery and /or laboratory assessments that might limit participation in or completion of the study protocol.
  • \* Diabetes
  • \* Use of medication that might have influence on endpoints (e.g. cholesterol lowering medication, hypertensive medication)
  • \* Administration of investigational drugs or participation in any scientific intervention study which may interfere with this study in the 180 days prior to this study
  • \* Use of antibiotics in the 30 days prior to the start of the study
  • \* Use of antioxidants, minerals and vitamin supplements available in pharmacies, drugstores, food markets or in alternative medicine
  • \* Pregnancy, lactation
  • \* Abuse of products (\> 20 alcoholic consumptions per week and drugs)
  • \* Weight gain or loss (\> 3 kg in previous 3 months)
  • \* High physical activity (\>4\.5 hours of running/week)

Investigators

Similar Trials